Hicef T 250mg/31.25mg Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Hicef T 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg), marketed as Hicef T, combats bacterial infections by inhibiting microbial growth. This combination medication requires administration by a healthcare provider. Complete the prescribed course, even with symptom improvement, to prevent treatment failure. Side effects may include nausea, vomiting, diarrhea, and indigestion. Severe reactions or worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, breathing difficulties) demand emergency care. Inform your doctor of all current medications, including those for pre-existing conditions, before use. Pregnant or breastfeeding individuals should seek medical advice. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration contribute to faster recovery. Monitoring through laboratory tests may be part of your treatment plan.
Uses of Hicef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Hicef T 250mg/31.25mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Hicef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Hicef T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Hicef T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Hicef T 250mg/31.25mg Injection, offer targeted antibacterial action. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Hicef T 250mg/31.25mg Injection with alcohol.
PregnancySAFE IF PRESCRIBED
Cefixime and Sulbactam injection (250mg/31.25mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Hicef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Hicef T 250mg/31.25mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Hicef T 250mg/31.25mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The 250mg/31.25mg Hicef T Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for this injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Hicef T 250mg/31.25mg Injection :
Omit a scheduled dose of Hicef T 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Hicef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently